Orally disintegrating tablets offer numerous advantages compared with traditional tablets and capsules, and can be an effective solution for developing line extensions of currently marketed therapies.

Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The "Orally Disintegrating Tablet Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, ...

The functionality and performance of three types of commercial superdisintegrants were evaluated in the application of orally disintegrating tablets. The orally disintegrating tablet (ODT) is a solid ...

When it comes to oral medication, both tablets and capsules are popular options. They both work by delivering a drug or supplement via your digestive tract for a specific purpose. Although tablets and ...

CT analysis of tablet microstructure reveals critical insights into disintegration and dissolution, driving improvements in ...

An Increase in Demand and Opportunities for the Global Orally Disintegrating Tablet Market by 2024,” offers a comprehensive analysis of the market by evaluating research and information from multiple ...

Takeda announced that the Food and Drug Administration (FDA) has approved Dexilant (dexlansoprazole) delayed-release capsules and Dexilant SoluTab delayed-release orally-disintegrating tablets for ...

The US Food and Drug Administration (FDA) has approved an amphetamine extended-release orally disintegrating tablet (Adzenys XR-ODT) for the treatment of attention ...

DALLAS and FORT WORTH, Texas, Jan. 27, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc.(Nasdaq:NEOS), a pharmaceutical company with a late‐stage pipeline of innovative extended-release (XR) product ...

SOLOTHURN, Switzerland - (NewMediaWire) - November 26, 2024 - Charles Ischi AG has been awarded the prestigious InnoPrix SO! for its innovative DISI Evo disintegration tester. The family business from ...